Leif Thuesen

25.8k total citations · 8 hit papers
257 papers, 14.4k citations indexed

About

Leif Thuesen is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Leif Thuesen has authored 257 papers receiving a total of 14.4k indexed citations (citations by other indexed papers that have themselves been cited), including 183 papers in Surgery, 180 papers in Cardiology and Cardiovascular Medicine and 111 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Leif Thuesen's work include Coronary Interventions and Diagnostics (174 papers), Cardiac Imaging and Diagnostics (110 papers) and Acute Myocardial Infarction Research (71 papers). Leif Thuesen is often cited by papers focused on Coronary Interventions and Diagnostics (174 papers), Cardiac Imaging and Diagnostics (110 papers) and Acute Myocardial Infarction Research (71 papers). Leif Thuesen collaborates with scholars based in Denmark, Netherlands and New Zealand. Leif Thuesen's co-authors include Patrick W. Serruys, Jens Flensted Lassen, Dariusz Dudek, Lars Romer Krusell, John A. Ormiston, Yoshinobu Onuma, Hans Erik Bøtker, Héctor M. García‐García, Evald Høj Christiansen and Henning Andersen and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

Leif Thuesen

251 papers receiving 13.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Comparison of Coronary Angioplasty with Fibrinolytic Therapy in Acute Myocardial Infarction

2003 916 citations Henning Andersen, Klaus Rasmussen et al. profile →
Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial

2010 731 citations Hans Erik Bøtker, Morten Bøttcher et al. The Lancet profile →
BENEFICIAL EFFECTS OF GROWTH HORMONE TREATMENT IN GH-DEFICIENT ADULTS

1989 726 citations Jens Otto Lunde Jørgensen, Leif Thuesen et al. The Lancet profile →
A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods

2009 584 citations Patrick W. Serruys, John A. Ormiston et al. The Lancet profile →
Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome

1997 572 citations Poul Erik Bloch Thomsen, Leif Thuesen et al. The Lancet profile →
A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial

2008 496 citations John A. Ormiston, Patrick W. Serruys et al. The Lancet profile →
Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction

2011 418 citations Henning Kelbæk, Hans Erik Bøtker et al. profile →
Evaluation of the Second Generation of a Bioresorbable Everolimus-Eluting Vascular Scaffold for the Treatment of De Novo Coronary Artery Stenosis

2011 414 citations Patrick W. Serruys, Yoshinobu Onuma et al. Journal of the American College of Cardiology profile →

Peers

Countries citing papers authored by Leif Thuesen

Since Specialization

Citations

This map shows the geographic impact of Leif Thuesen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leif Thuesen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leif Thuesen more than expected).

Fields of papers citing papers by Leif Thuesen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leif Thuesen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leif Thuesen. The network helps show where Leif Thuesen may publish in the future.

Co-authorship network of co-authors of Leif Thuesen

This figure shows the co-authorship network connecting the top 25 collaborators of Leif Thuesen. A scholar is included among the top collaborators of Leif Thuesen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leif Thuesen. Leif Thuesen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Chronic total coronary occlusion: treatment results 2017 ·Scandinavian Cardiovascular Journal ·(unknown), (unknown), (unknown), Anton Boel Villadsen, Bent Raungaard, Svend Eggert Jensen, Leif Thuesen	6
2	Intravascular ultrasound assessment of minimum lumen area and intimal hyperplasia in in-stent restenosis after drug-eluting or bare-metal stent implantation. The Nordic Intravascular Ultrasound Study (NIVUS) 2017 ·Cardiovascular revascularization medicine ·Lisette Okkels Jensen, Saila Vikman, Lisbeth Antonsen, (unknown), Matti Niemelä, Evald Høj Christiansen, Kari Kervinen, Andrejs Ērglis, Jan Harnek, Indulis Kumsārs, Leif Thuesen, Kari Niemelä	15
3	Similar five-year outcome with paclitaxel- and sirolimus-eluting coronary stents 2014 ·Scandinavian Cardiovascular Journal ·(unknown), Leif Thuesen, Kari Saunamäki, Per Thayssen, Jens Aarøe, Peter Riis Hansen, Jens Flensted Lassen, (unknown), Jørgen Jeppesen, Anders Galløe, (unknown)	7
4	TCT-34 The appearance of jailed side branches post-procedure, at 6, 12, 24 and 36 months following implantation of bioresorbable vascular devices - Insights from the ABSORB Cohort B trial using three-dimensional optical coherence tomography 2013 ·Journal of the American College of Cardiology ·Yoshinobu Onuma, Héctor M. García‐García, Jacques Koolen, Takashi Muramatsu, Shimpei Nakatani, John A. Ormiston, Patrick W. Serruys, Leif Thuesen, Robert J. Van Geuns, Robert Whitbourn, Stephan Windecker	3
5	Long-Term Outcome After Drug-Eluting Versus Bare-Metal Stent Implantation in Patients With ST-Segment Elevation Myocardial Infarction 2013 ·JACC: Cardiovascular Interventions ·Lene Holmvang, Henning Kelbæk, Anne Kaltoft, Leif Thuesen, Jens Flensted Lassen, Peter Clemmensen, Lene Kløvgaard, Thomas Engstrøm, Hans Erik Bøtker, Kari Saunamäki, Lars Romer Krusell, Erik Jørgensen, Hans–Henrik Tilsted, Evald Høj Christiansen, Jan Ravkilde, Lars Køber, Klaus F. Kofoed, Christian Juhl Terkelsen, Steffen Helqvist	31
6	Head-to-Head Comparison of the Neointimal Response Between Metallic and Bioresorbable Everolimus-Eluting Scaffolds Using Optical Coherence Tomography 2011 ·JACC: Cardiovascular Interventions ·Josep Gómez‐Lara, Salvatore Brugaletta, Vasim Farooq, Yoshinobu Onuma, Roberto Diletti, Stephan Windecker, Leif Thuesen, Dougal McClean, Jacques Koolen, Robert Whitbourn, Dariusz Dudek, Pieter C. Smits, Bernard Chevalier, Evelyn Regar, Susan Veldhof, Richard Rapoza, John A. Ormiston, Héctor M. García‐García, Patrick W. Serruys	51
7	Abstract 10570: ABSORB Cohort A Trial: Five Year Clinical and MSCT Results of the ABSORB Bioresorbable Everolimus Eluting Vascular Scaffold 2011 ·Circulation ·Koen Nieman, Dariusz Dudek, (unknown), Leif Thuesen, Patrick W. Serruys	2
8	Long-Term Outcome After Drug-Eluting Versus Bare-Metal Stent Implantation in Patients With ST-Segment Elevation Myocardial Infarction 2010 ·Journal of the American College of Cardiology ·Anne Kaltoft, Henning Kelbæk, Leif Thuesen, Jens Flensted Lassen, Peter Clemmensen, Lene Kløvgaard, Thomas Engstrøm, Hans Erik Bøtker, Kari Saunamäki, Lars Romer Krusell, Erik Jørgensen, Hans-Henrik Tilsted, Evald Høj Christiansen, Jan Ravkilde, Lars Køber, Klaus F. Kofoed, Christian Juhl Terkelsen, Steffen Helqvist	58
9	Monitoring In Vivo Absorption of a Drug-Eluting Bioabsorbable Stent With Intravascular Ultrasound-Derived Parameters 2010 ·JACC: Cardiovascular Interventions ·Nico Bruining, Sebastiaan de Winter, Jos R.T.C. Roelandt, Evelyn Regar, Iddo Heller, Ron T. van Domburg, Ronald Hamers, Yoshinobu Onuma, Darius Dudek, Mark Webster, Leif Thuesen, John A. Ormiston, Wai‐Fung Cheong, Karine Miquel‐Hébert, Susan Veldhof, Patrick W. Serruys	30
10	3-Dimensional Optical Coherence Tomography Assessment of Jailed Side Branches by Bioresorbable Vascular Scaffolds 2010 ·JACC: Cardiovascular Interventions ·Takayuki Okamura, Yoshinobu Onuma, Héctor M. García‐García, Evelyn Regar, Joanna J. Wykrzykowska, Jacques Koolen, Leif Thuesen, Stefan Windecker, Robert Whitbourn, Dougal R. McClean, John A. Ormiston, Patrick W. Serruys	74
11	Long-Term Outcome in Patients Treated With Sirolimus-Eluting Stents in Complex Coronary Artery Lesions 2008 ·Journal of the American College of Cardiology ·Henning Kelbæk, Lene Kløvgaard, Steffen Helqvist, Jens Flensted Lassen, Lars Romer Krusell, Thomas Engstrøm, Hans Erik Bøtker, Erik Jørgensen, Kari Saunamäki, (unknown), Per Thayssen, Anders Galløe, Gunnar V.H. Jensen, Leif Thuesen	40
12	Stent thrombosis, myocardial infarction, and mortality following drug-eluting and bare metal stent coronary interventions in patients with diabetes mellitus 2007 ·The American Journal of Cardiology ·Michael Mæng, Lisette Okkels Jensen, Anne Kaltoft, Morten Bøttcher, (unknown), Søren Paaske Johnsen, Lars Pedersen, Henrik Toft Sørensen, Klaus Rasmussen, Jens Flensted Lassen, Per Thayssen, Leif Thuesen	4
13	Efficiency and safety of the sirolimus eluting stent in complex coronary artery lesions after cessation of dual antiplatelet therapy: fifteen months clinical outcome of the randomised Stenting Coronary Arteries in Non-stress/benestent Disease (SCANDSTENT) trial 2007 ·EuroIntervention ·Steffen Helqvist, Henning Kelbæk, Leif Thuesen, Lene Kløvgaard, Lars Romer Krusell, Erik Jørgensen, Hans Erik Bøtker, Gunnar V.H. Jensen, Jens Flensted Lassen, Per Thayssen, Anders Galløe, Kari Saunamäki	3
14	The Stenting Coronary Arteries in Non-stress/benestent Disease (SCANDSTENT) Trial 2005 ·Journal of the American College of Cardiology ·Henning Kelbæk, Leif Thuesen, Steffen Helqvist, Lene Kløvgaard, Erik Jørgensen, (unknown), Kari Saunamäki, Lars Romer Krusell, Gunnar V.H. Jensen, Hans Erik Bøtker, Jens Flensted Lassen, Henning Andersen, Per Thayssen, Anders Galløe, (unknown)	76
15	Intramyocardial Injection of Genes with a Novel Percutaneous Technique: Initial Safety Data of the Euroinject One Study 2001 ·Jens Kastrup, Erik Jørgensen, Viktor Drvota, Leif Thuesen, Hans Erik Bøtker, (unknown), Dietmar Glogar, Andreas Rück, Khalid B. Islam, Christer Sylvén	7
16	Prospective randomised trial of atrial versus ventricular pacing in sick-sinus syndrome 1994 ·The Lancet ·Henrik Rasmus Andersen, Leif Thuesen, Jens P. Bagger, Thomas Vesterlund, Poul Erik Bloch Thomsen	331
17	Long-term growth hormone treatment in growth hormone deficient adults 1991 ·European Journal of Endocrinology ·Jens Otto Lunde Jørgensen, Søren Anker Pedersen, Leif Thuesen, Jørgen Jørgensen, Jens Møller, Jørn Müller, Niels E. Skakkebæk, Jens Sandahl Christiansen	103
18	Increased myocardial contractility following growth hormone administration in normal man. An echocardiographic study. 1988 ·PubMed ·Leif Thuesen, J. S. Christiansen, Keld E. Sørensen, Jens Otto Lunde Jørgensen, (unknown), P Henningsen	79
19	One-year experience with a low-fat, low-cholesterol diet in patients with coronary heart disease 1986 ·American Journal of Clinical Nutrition ·Leif Thuesen, (unknown), (unknown)	41
20	Effect of verapamil on enzyme release after early intravenous administration in acute myocardial infarction: double blind randomised trial. 1983 ·BMJ ·Leif Thuesen, (unknown), (unknown), Jens Ahm Sørensen, Michael Væth, (unknown), (unknown), L Hagerup	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact